ConductScience.org, home

Paper14501

Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.

Atterhög JH and 2 others. Am J Med, 1976. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. Papers, record 14501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14501

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
PubMed
Journal
Am J Med
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
3.45
iCite
Revised in PubMed
2019-06-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Atterhög JHJ H
2Dunér HH
3Pernow BB

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
HypertensionMajor topic
PindololMajor topic
Blood Pressure
Cardiac Output
Depression, Chemical
Drug Evaluation
Heart Rate
Humans
Middle Aged
Regional Blood Flow
Vascular Resistance

Source PubMed

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05882864Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus With Immunohistochemical AnalysisBackground

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
42,653,285General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors.Int J Mol Sci2026https://conductscience.org/library/papers/42653285PubMed
37,511,110Artificial Intelligence in Decrypting Cytoprotective Activity under Oxidative Stress from Molecular Structure.Int J Mol Sci2023https://conductscience.org/library/papers/37511110PubMed
7,104,149Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104149PubMed
7,104,147Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104147PubMed
7,049,208Pindolol--the pharmacology of a partial agonist.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7049208PubMed
6,147,240Hypertension in pregnancy. Pathophysiology and management.Drugs1984https://conductscience.org/library/papers/6147240PubMed
6,125,176Effects of beta-adrenoceptor antagonists on central haemodynamics in essential hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125176PubMed
6,125,175How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125175PubMed
6,125,173Peripheral haemodynamic effects of beta-adrenoceptor blocking drugs with ISA or relative beta 1-selectivity at rest and during physical exercise.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125173PubMed
6,125,169Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125169PubMed
3,326,634Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3326634PubMed
2,894,223Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.Br J Clin Pharmacol1987https://conductscience.org/library/papers/2894223PubMed
2,076,384Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2076384PubMed
1,747,577beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.BMJ1991https://conductscience.org/library/papers/1747577PubMed
371,643Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.Br Heart J1979https://conductscience.org/library/papers/371643PubMed
43,164A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/43164PubMed
38,968Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/38968PubMed
25,186Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/25186PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14501

GET https://conductscience.org/api/papers/v1/14501/authors